Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions

Neuroscience

Volumn 83, Issue 3, 1998, Pages 741-748

  Volpe, B T ^a   Wildmann, J ^a   Altar, C A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Neurodegenerative disease; Neuroprotection; Striatonigral; Transneuronal degeneration; Trophic factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; IBOTENIC ACID; NEUROPROTECTIVE AGENT; NEUROTROPHIN 3;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; GABAERGIC SYSTEM; HUNTINGTON CHOREA; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COUNT; CELL DEATH; CORPUS STRIATUM; GLOBUS PALLIDUS; MALE; NEUROTOXINS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 0032484557     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00424-7     Document Type: Article

References (53)

1. 1. Albin R. L. and Greenamyre J. T. (1992) Alternative excitotoxicity hypothesis. Neurology 42, 733-738.
2. 2. Alexander G. E., Crutcher M. D. and DeLong M. R. (1990) Basal ganglia thalamo-cortical circuits. Prog. Brain Res. 89, 119-146.
3. 125I]neurotrophin-3 binding to mammalian brain. J. Neurosci. 13, 733-743.
4. 4. Altar C. A., Boylan C. B., Pritsche M., Jackson C., Hyman C. and Lindsay R. M. (1994) The neurotrophins NT-4/5 and BDNF activate serotonin, dopamine, and GABA neurons following behaviorally effective infusions to the substantia nigra. Expl Neurol. 130, 31-40.
5. 125I]NT-3. Eur. J. Neurosci. 6, 1389-1405.
6. 6. Ardelt A. A., Flaris N. and Roth K. A. (1994) Neurotrophin-4 selectively promotes survival of striatal neurons in organotypic slice culture. Brain Res. 647, 340-344.
7. 7. Arenas E. and Person H. (1994) Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367, 368-370.
8. 8. Arenas E., Äkerud P., Wong V., Boylan C. B., Persson H., Lindsay R. M. and Altar C. A. (1996) Effects of BDNF and NT-4/5 infusions on striatonigral neuropeptides or nigral GABA neurons in rat brain. Eur. J. Neurosci. 8, 1707-1717.
9. 9. Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative disease? Ann. Neurol. 31, 119-130.
10. 10. Blandini F., Porter R. H. P. and Greenamyre J. T. (1996) Glutamate and Parkinson's disease. Molec. Neurobiol. 12, 73-94.
11. 11. Cheng B. and Mattson M. P. (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640, 56-67.
12. 12. Coggeshall R. and Lekan H. A. (1996) Method for determining numbers of cells and synapses: A case for more uniform standards of review. J. comp. Anat. 364, 6-15.
13. 13. Cowan W. M. (1970) Antero and retrograde transneuronal degeneration in the central and peripheral nervous system. In Contemporary Research Methods in Neuroanatomy (eds Nauta W. H. J. and Ebbesson S.), pp. 217-251. Springer-Verlag, New York.
14. 14. Forno L. S. (1983) Reaction of the SN to massive basal ganglia infarction. Acta neuropath. 62, 96-102.
15. 15. Forno L. S. (1990) Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies. In Parkinson's Disease (ed Stern G.), p. 215. Johns Hopkins University Press, Baltimore.
16. 16. Forno L. S. (1996) Neuropathology of Parkinson's disease. J. Neuropath. exp. Neurol. 55, 259-272.
17. 17. Gerfen C. R. (1985) The neostriatal mosaic: 1. Compartment organization of the projections from the neostriatum to the substantia nigra in the rat. J. comp. Neurol. 236, 454-476.
18. 18. Gunderson H. J. G. (1986) Stereology of arbitrary particles. A review of unbiased number and size of estimators and the presentation of some new ones. J. Microsc. 143, 3-45.
19. 19. Gunderson H. J. G. (1992) Stereology: the fast lane between neuroanatomy and brain function - or still only a tightrope? Acta neurol. scand. 137, 8-13.
20. 20. Hardman C. D., McRitchie D. A., Halliday G. M., Cartwright H. R. and Morris J. G. (1996) Substantia nigra pars reticulata neurons in Parkinson's disease. Neurodegeneration 5, 49-55.
21. 21. Hirsch E., Graybiel A. M. and Agid Y. A. (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334, 345-348.
22. 22. Hyman C., Juhasz M. and Lindsay R. M. (1994) Overlapping and distinct actions of the neurotrophins of BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14, 335-347.
23. 23. Ip N. Y., Li Y., Yancopoulos G. D. and Lindsay R. M. (1993) Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF. J. Neurosci. 13, 3394-3405.
24. 24. Jones K. R., Farinas I., Backus C. and Reichardt L. F. (1994) Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76, 989-999.
25. 25. Koh J.-Y., Gwag B. J., Lobner D. and Choi D. W. (1995) Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 268, 573-575.
26. 26. Koliatsos V. E., Clatterbuck R. E., Winslow J. W., Cayouette M. H. and Price D. L. (1993) Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 10, 359-367.
27. 27. Krammer E. B. (1980) Anterograde and transynaptic degeneration "en cascade" in basal ganglia induced by intrastriatal injection of kainic acid. Brain Res. 196, 209-221.
28. 28. Lindsay R. M., Altar C. A., Cedarbaum J., Hyman C. and Wiegand S. J. (1993) The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Expl Neurol. 124, 103-118.
29. 29. Lindsay R. M., Wiegand S. J., Altar C. A. and DiStefano P. S. (1994) Neurotrophic factors: from molecule to man. Trends Neurosci. 17, 182-190.
30. 30. Martin-Iverson M. T., Todd K. G., and Altar C. A. (1994) Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interaction with amphetamine. J. Neurosci. 14, 1262-1270.
31. 31. Merlio J. P., Ernfors P., Jaber C. and Persson H. (1992) Molecular cloning of rat trkC and distribution of cells expressing messenger RNA's for members of the trk family in the rat central nervous system. Neuroscience 51, 513-532.
32. 32. Mizuno K., Carnahan J. and Nawa H. (1994) Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Devl Biol. 165, 243-256.
33. 33. Morse J. K., Wiegand S. J., Anderson K. A., You Y., Cai N., DiStefano P. S., Altar C. A., Lindsay R. M. and Alderson R. F. (1993) Brain-derived neurotrophic factor (BDNF) increases the survival of basal forebrain cholinergic neurons following a fimbria-fornix transection. J. Neurosci. 13, 4146-4156.
34. 34. Mullen R. J., Buck C. R. and Smith A. M. (1992) Neu-N, a neuronal specific nuclear protein in vertebrates. Development 116, 201-211.
35. 35. Nakane M., Teraoka A., Asato R. and Tamura A. (1992) Degeneration of the ipsilateral substantia nigra following cerebral infarction in the striatum. Stroke 23, 328-332.
36. 36. Nakao N., Kaokaia Z., Odin P. and Lindvall O. (1995) Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons. Expl Neurol. 131, 1-10.
37. 37. Oyanagi K., Takeda S., Takahashi H., Ohama E. and Ikuta F. (1989) A quantitative investigation of the substantia nigra in Huntington's disease. Ann. Neurol. 26, 13-19.
38. 38. Pakkenbergh H. and Brody H. (1965) The number of nerve cells in the substantia nigra in paralysis agitans. Acta neuropath. 5, 320-324.
39. 39. Pasinetti G. M., Morgan D. G. and Finch C. E. (1991) Disappearance of GAD mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions. Expl Neurol. 112, 131-139.
40. 40. Quarrell O. (1991) The neurobiology of Huntington's disease. In Huntington's Disease (ed Harper P. S.), Vol. 22, pp. 141-178. Saunders, New York.
41. 41. Rosenthal R. L. and Rosnow D. B. (1985) Contrast Analysis: Comparisons in the Analysis of Variance. Cambridge University Press, Cambridge, England.
42. 42. Saji M. and Reis D. J. (1986) Delayed transneuronal death of SN neurons prevented by GABA antagonist. Science 235, 66-68.
43. 43. Saji M. and Volpe B. T. (1993) Delayed histologic damage and neuron death in the SNR following transient forebrain ischemia depends on the extent of striatal injury. Neurosci. Lett. 155, 47-50.
44. 44. Saji M., Cohen M., Blau A. D., Wessel T. C. and Volpe B. T. (1994) Transient forebrain ischemia induces delayed injury in the substantia nigra reticulata: degeneration of GABA neurons, compensatory expression of GAD mRNA. Brain Res. 643, 234-244.
45. 45. Saji M., Blau A. D. and Volpe B. T. (1996) Prevention of transneuronal degeneration in the substantia nigra reticulata by ablation of the subthalamic nucleus. Expl Neuropl. 141, 120-129.
46. 46. Saji M., Endo Y., Miyanishi T., Volpe B. T. and Ohno K. (1997) Movement disorders after substantia nigra reticulata transneuronal degeneration and rescue. Behav. Brain Res. 84, 63-71.
47. 47. Sendtner M., Holtmann B., Kolbeck R., Thoenen H. and Barde Y.-A. (1993) Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360, 757-759.
48. 48. Shimohama S., Tamura Y., Akaike A., Tsukahara T., Ohara O., Watanabe S. and Kimura J. (1993) BDNF pretreatment exerts a partially protective effect against glutamate induced neurotoxicity in cultured rat cortical neurons. Neurosci. Lett. 164, 55-58.
49. 49. Spina M. B., Squinto S. P., Miller J., Lindsay R. M. and Hyman C. (1992) BDNF protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99-106.
50. 50. Strefling A. M. and Eric H. (1982) Cross cerebellar atrophy: an old problem revisited. Acta neuropath. 57, 97-102.
51. 51. Ventimiglia R., Mather P., Jones B. E. and Lindsay R. M. (1995) The neurotrophins BDNF, NT-3, and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 7, 213-222.
52. 52. Volpe B. T., Blau A. D., Wessel T. C. and Saji M. (1995) Delayed histopathological neuronal damage in the substantia nigra compacta (nucleus A9) after transient forebrain ischemia. Neurobiol. Disease 2, 119-127.
53. 53. Yan Q., Elliott J. and Snider W. D. (1993) Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 360, 753-755.